COMP <GO>
ZTO vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
ZTO Express (Cayman) Inc. American (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ZTO 9
— TMO 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ZTO
LAST: $20.15 (+1.36%) • MKT CAP: $15.31B
roic
12.50%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZTO VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZTO | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.00% | 41.00% | -16.00 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 12.50% | 9.30% | +3.20 | ZTO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.2x | 30.4x | -23.20 | ZTO | /valuation <GO> |
| Free Cash Flow Yield | 6.31% | 2.40% | +3.91 | ZTO | /fcf-yield <GO> |
| Operating Margin | 21.30% | 17.40% | +3.90 | ZTO | /operating-margins <GO> |
| Net Profit Margin | 18.50% | 15.10% | +3.40 | ZTO | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 3.90% | +2.70 | ZTO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.51% | 0.24% | +3.27 | ZTO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.41 | 4.50 | -0.09 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.70% | +0.60 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.6 | 59.1 | -8.57 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.94 | +0.17 | ZTO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.0x | 36.3x | -25.30 | ZTO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.31B | $262.22B | -$246.91B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZTO REV | TMO REV | ZTO GROSS % | TMO GROSS % | ZTO FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.02B | $44.56B | 25.0% | 44.0% | $965.8M | $6.29B |
| FY 2024 | $6.07B | $42.88B | 31.0% | 44.0% | $852.3M | $7.27B |
| FY 2023 | $0 | $42.86B | — | 44.0% | $1.88B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZTO // BETA 1.11
TMO // BETA 0.94